Jitendra Mohan sold $12M of ALAB
Chief Executive Officer at Astera Labs, Inc.. 126,258 shares at an average of $96.50, traded Jul 17, 2025, filed Jul 21, 2025.
Score components
- +25RoleCEO
- +25Trade size$12.2M at market
- 0Share of holdings soldSold 2.9% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001736297-25-000084, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 17, 2025 | SOpen-market sale Common Stockindirect: By Living Trust10b5-1 | -13,418 | $94.37 | $1.3M | 4,325,758 | Jul 21, 2025 |
| Jul 17, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -13,417 | $94.37 | $1.3M | 745,749 | Jul 21, 2025 |
| Jul 17, 2025 | SOpen-market sale Common Stockindirect: By 2021 Trust 110b5-1 | -13,417 | $94.37 | $1.3M | 745,756 | Jul 21, 2025 |
| Jul 17, 2025 | SOpen-market sale Common Stockindirect: By 2021 Trust 210b5-1 | -13,417 | $94.37 | $1.3M | 745,756 | Jul 21, 2025 |
| Jul 17, 2025 | SOpen-market sale Common Stockindirect: By 2022 Trust 110b5-1 | -13,417 | $94.37 | $1.3M | 495,757 | Jul 21, 2025 |
| Jul 17, 2025 | SOpen-market sale Common Stockindirect: By 2022 Trust 210b5-1 | -13,417 | $94.37 | $1.3M | 495,757 | Jul 21, 2025 |
| Jul 18, 2025 | SOpen-market sale Common Stockindirect: By Living Trust10b5-1 | -7,625 | $100.25 | $764k | 4,318,133 | Jul 21, 2025 |
| Jul 18, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -7,626 | $100.25 | $765k | 738,123 | Jul 21, 2025 |
| Jul 18, 2025 | SOpen-market sale Common Stockindirect: By 2021 Trust 110b5-1 | -7,626 | $100.25 | $765k | 738,130 | Jul 21, 2025 |
| Jul 18, 2025 | SOpen-market sale Common Stockindirect: By 2021 Trust 210b5-1 | -7,626 | $100.25 | $765k | 738,130 | Jul 21, 2025 |
| Jul 18, 2025 | SOpen-market sale Common Stockindirect: By 2022 Trust 110b5-1 | -7,626 | $100.25 | $765k | 488,131 | Jul 21, 2025 |
| Jul 18, 2025 | SOpen-market sale Common Stockindirect: By 2022 Trust 210b5-1 | -7,626 | $100.25 | $765k | 488,131 | Jul 21, 2025 |
Related signals
Other insiders at Astera Labs, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $4.7M 12,499 shares | -25% | |
| 33Weak | Astera Labs, Inc. | Manuel Alba director | $51M 183,000 shares | -14% | |
| 33Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $3.4M 12,499 shares | -23% | |
| 38Weak | Astera Labs, Inc. | Jitendra Mohan Chief Executive Officer | $21M 157,500 shares | -3% | |
| 24Weak | Astera Labs, Inc. | Jack R Lazar director | $325k 2,500 shares | -3% | |
| 34Weak | Astera Labs, Inc. | Jack R Lazar director | $898k 7,500 shares | -8% | |
| 35Weak | Astera Labs, Inc. | Philip Mazzara General Counsel and Secretary | $1.2M 10,000 shares | -7% | |
| 62Notable | Astera Labs, Inc. | Michael Truett Tate Chief Financial Officer | $1.5M 12,001 shares | -6% | |
| 65Notable | Astera Labs, Inc. | Jitendra Mohan Chief Executive Officer | $12M 94,971 shares | -6% | |
| 49Moderate | Astera Labs, Inc. | Philip Mazzara General Counsel and Secretary | $600k 4,849 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.